Positive data from Sanifit’s Phase 2b CaLIPSO trial of SNF472 published in Circulation

    NEXT STORY
    Oncology Venture reaches new development milestone with Dovitinib.
    PREV STORY
    Oncology Venture is streamlining its communications by publishing press releases in English only going forward.
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    TLC and Jixi Biotechnology Partners Announce Joint Venture

    TAIPEI, Taiwan, Jan. 23, 2018 (GLOBE NEWSWIRE) -- TLC (4152.TT) today announced that it ...

    author_avatar
    NASDAQ Market News

    Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis

    author_avatar
    NASDAQ Market News

    ABLYNX ANNOUNCES 2017 HALF YEAR RESULTS AND YEAR-TO-DATE BUSINESS UPDATE

    REGULATED INFORMATION Important progress in key programmes and a strategic collaboration with Sanofi Conference ...

    author_avatar
    NASDAQ Market News